This product is an active protein and may elicit a biological response in vivo, handle with caution.
Reconstitute the lyophilized product in 100 µl sterile deionized water to a final concentration of 1 mg/ml. Solubilize for 30 to 60 minutes at room temperature with occasional gentle mixing. Carrier protein (0.1% HSA or BSA) is strongly recommended for further dilution and long term storage. 5-10% trehalose is commonly used for freeze drying, and after reconstitution, the trehalose is mostly about 3-5%
CD300 antigen-like family member A
CMRF 35 H9
CMRF35-like molecule 8
CMRF35H leukocyte immunoglobulin like receptor
Immunoglobulin superfamily member 12
Inhibitory receptor protein 60
Leukocyte membrane antigen
Mast cell derived paired immunoglobulin like receptor 1
NK inhibitory receptor
Polymeric immunoglobulin receptor 4
Inhibitory receptor which may contribute to the down-regulation of cytolytic activity in natural killer (NK) cells, and to the down-regulation of mast cell degranulation.
Expressed not only by natural killer (NK) cells but also by T-cell subsets, B-cells, dendritic cells, mast cells, granulocytes and monocytes.
Belongs to the CD300 family. Contains 1 Ig-like V-type (immunoglobulin-like) domain.
SDS-PAGE - Recombinant human CD300 antigen protein (Active) (ab185267)
DTT-reduced (+) and non-reduced (-) SDS-PAGE analysis of ab185267, and staining overnight with Coomassie Blue. As a result of glycosylation, DTT-reduced Protein migrates as 52-66 kDa and non-reduced protein migrates as 105-130 kDa.
has not yet been referenced specifically in any publications.
Publishing research using ab185267? Please let us know so that we can cite the reference in this datasheet.
Customer reviews and Q&As
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up